A citation-based method for searching scientific literature

Meena S Moran, Yinjun Zhao, Shuangge Ma, Youlia Kirova, Alain Fourquet, Peter Chen, Karen Hoffman, Kelly Hunt, Julia Wong, Lia M Halasz, Gary Freedman, Robert Prosnitz, Michael Yassa, David H A Nguyen, Tarek Hijal, Bruce G Haffty, Elaine S Wai, Pauline T Truong. JAMA Oncol 2017
Times Cited: 36







List of co-cited articles
181 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
207
44

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
360
41

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
422
41

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
191
36

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
305
36

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
142
33


Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Harry Bartelink, Philippe Maingon, Philip Poortmans, Caroline Weltens, Alain Fourquet, Jos Jager, Dominic Schinagl, Bing Oei, Carla Rodenhuis, Jean-Claude Horiot,[...]. Lancet Oncol 2015
285
30

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.
M Luke Marinovich, Lamiae Azizi, Petra Macaskill, Les Irwig, Monica Morrow, Lawrence J Solin, Nehmat Houssami. Ann Surg Oncol 2016
77
25

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
101
22

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Joanne S Haviland, J Roger Owen, John A Dewar, Rajiv K Agrawal, Jane Barrett, Peter J Barrett-Lee, H Jane Dobbs, Penelope Hopwood, Pat A Lawton, Brian J Magee,[...]. Lancet Oncol 2013
654
22

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Benjamin D Smith, Jennifer R Bellon, Rachel Blitzblau, Gary Freedman, Bruce Haffty, Carol Hahn, Francine Halberg, Karen Hoffman, Kathleen Horst, Jean Moran,[...]. Pract Radiat Oncol 2018
231
22

Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
B Cutuli, N Wiezzane, I Palumbo, P Barbieri, M Guenzi, A Huscher, S Borghesi, C Delva, T Iannone, E Vianello,[...]. Cancer Radiother 2016
10
80

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.
Monica Morrow, Kimberly J Van Zee, Lawrence J Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R Harris, Janet Horton, Shelley Hwang, Peggy L Johnson, M Luke Marinovich,[...]. Ann Surg Oncol 2016
102
19

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
299
19

Long-term results of hypofractionated radiation therapy for breast cancer.
Timothy J Whelan, Jean-Philippe Pignol, Mark N Levine, Jim A Julian, Robert MacKenzie, Sameer Parpia, Wendy Shelley, Laval Grimard, Julie Bowen, Himu Lukka,[...]. N Engl J Med 2010
952
19

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
Harry Bartelink, Jean-Claude Horiot, Philip M Poortmans, Henk Struikmans, Walter Van den Bogaert, Alain Fourquet, Jos J Jager, Willem J Hoogenraad, S Bing Oei, Carla C Wárlám-Rodenhuis,[...]. J Clin Oncol 2007
630
19

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
H Bartelink, J C Horiot, P Poortmans, H Struikmans, W Van den Bogaert, I Barillot, A Fourquet, J Borger, J Jager, W Hoogenraad,[...]. N Engl J Med 2001
622
16

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.
Aurelius Omlin, Maurizio Amichetti, David Azria, Bernard F Cole, Philippe Fourneret, Philip Poortmans, Diana Naehrig, Robert C Miller, Marco Krengli, Cristina Gutierrez Miguelez,[...]. Lancet Oncol 2006
88
16


Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
I Meattini, L Livi, D Franceschini, C Saieva, F Meacci, L Marrazzo, B Bendinelli, V Scotti, C De Luca Cardillo, J Nori,[...]. Eur J Surg Oncol 2013
22
27

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
300
16

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.
P Romestaing, Y Lehingue, C Carrie, R Coquard, X Montbarbon, J M Ardiet, N Mamelle, J P Gérard. J Clin Oncol 1997
450
16

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
170
16

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
74
13


Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
Lawrence J Solin, Alain Fourquet, Frank A Vicini, Marie Taylor, Ivo A Olivotto, Bruce Haffty, Eric A Strom, Lori J Pierce, Lawrence B Marks, Harry Bartelink,[...]. Cancer 2005
122
13

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
183
13

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
179
13

Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Nafisha Lalani, Lawrence Paszat, Rinku Sutradhar, Deva Thiruchelvam, Sharon Nofech-Mozes, Wedad Hanna, Elzbieta Slodkowska, Susan J Done, Naomi Miller, Bruce Youngson,[...]. Int J Radiat Oncol Biol Phys 2014
39
13

Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Philip Wong, Christine Lambert, Ramanakumar V Agnihotram, Marc David, Marie Duclos, Carolyn R Freeman. Int J Radiat Oncol Biol Phys 2012
36
13

Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ.
Elaine S Wai, Mary L Lesperance, Cheryl S Alexander, Pauline T Truong, Matthew Culp, Patricia Moccia, Jennifer F Lindquist, Ivo A Olivotto. Cancer 2011
38
13

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Yasuaki Sagara, Rachel A Freedman, Ines Vaz-Luis, Melissa Anne Mallory, Stephanie M Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. J Clin Oncol 2016
79
13

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Amélie Monteau, Brigitte Sigal-Zafrani, Youlia M Kirova, Virginie Fourchotte, Marc A Bollet, Anne Vincent-Salomon, Bernard Asselain, Remy J Salmon, Alain Fourquet. Int J Radiat Oncol Biol Phys 2009
25
20

Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.
Elizabeth Shurell, Cristina Olcese, Sujata Patil, Beryl McCormick, Kimberly J Van Zee, Melissa L Pilewskie. Cancer 2018
21
23

Radiotherapy in DCIS, an underestimated benefit?
Bruno Cutuli, Jacques Bernier, Philip Poortmans. Radiother Oncol 2014
25
16

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.
B Cutuli, C Lemanski, A Fourquet, B de Lafontan, S Giard, A Meunier, R Pioud-Martigny, F Campana, H Marsiglia, S Lancrenon,[...]. Br J Cancer 2009
42
11

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
834
11

Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
Ann C Raldow, David Sher, Aileen B Chen, Abram Recht, Rinaa S Punglia. J Clin Oncol 2016
38
11

Hypofractionated radiation therapy for breast ductal carcinoma in situ.
Lara Hathout, Tarek Hijal, Valérie Théberge, Bernard Fortin, Horia Vulpe, Jean-Charles Hogue, Christine Lambert, Houda Bahig, Louise Provencher, Peter Vavassis,[...]. Int J Radiat Oncol Biol Phys 2013
28
14

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
129
11

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
430
11


Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Conny Vrieling, Erik van Werkhoven, Philippe Maingon, Philip Poortmans, Caroline Weltens, Alain Fourquet, Dominic Schinagl, Bing Oei, Carla C Rodenhuis, Jean-Claude Horiot,[...]. JAMA Oncol 2017
69
11

Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.
Eileen Rakovitch, Steven A Narod, Sharon Nofech-Moses, Wedad Hanna, Deva Thiruchelvam, Refik Saskin, Carole Taylor, Alan Tuck, Bruce Youngson, Naomi Miller,[...]. Int J Radiat Oncol Biol Phys 2013
25
16

Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Rinku Sutradhar, Sumei Gu, Cindy Fong, Alan Tuck, Bruce Youngson, Naomi Miller, Susan J Done,[...]. Breast 2018
10
40


A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk.
Troy Bremer, Pat W Whitworth, Rakesh Patel, Jess Savala, Todd Barry, Stephen Lyle, Glen Leesman, Steven P Linke, Karin Jirström, Wenjing Zhou,[...]. Clin Cancer Res 2018
31
12

Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
134
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.